ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,00%
Bitcoin
66.792,40
-0,43%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. GeneDx Holdings Corporation (WGS)

  7. GeneDx Holdings Corporation (WGS) News

WGS

GeneDx (WGS)

GeneDx Holdings Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:WGS
DatumZeitQuelleÜberschriftSymbolFirma
29/04/202422h05GlobeNewswire Inc.GeneDx Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
23/04/202414h30GlobeNewswire Inc.GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease DatasetNASDAQ:WGSGeneDx Holdings Corporation
04/04/202422h05GlobeNewswire Inc.GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024NASDAQ:WGSGeneDx Holdings Corporation
14/03/202413h30GlobeNewswire Inc.GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of GenomicsNASDAQ:WGSGeneDx Holdings Corporation
05/03/202422h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
26/02/202422h05GlobeNewswire Inc.GeneDx to Participate in 44th Annual Cowen Health Care ConferenceNASDAQ:WGSGeneDx Holdings Corporation
23/02/202422h56Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:WGSGeneDx Holdings Corporation
20/02/202422h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
20/02/202422h26GlobeNewswire Inc.GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024NASDAQ:WGSGeneDx Holdings Corporation
01/02/202422h30GlobeNewswire Inc.GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 NASDAQ:WGSGeneDx Holdings Corporation
24/01/202422h30GlobeNewswire Inc.GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
23/01/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
08/01/202414h58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
08/01/202414h55GlobeNewswire Inc.GeneDx Announces Preliminary 2023 Financial ResultsNASDAQ:WGSGeneDx Holdings Corporation
04/01/202423h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
03/01/202422h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
20/12/202303h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
20/12/202303h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
12/12/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
12/12/202322h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
05/12/202322h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
01/12/202314h30GlobeNewswire Inc.GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with EpilepsyNASDAQ:WGSGeneDx Holdings Corporation
28/11/202322h05GlobeNewswire Inc.GeneDx to Participate in 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:WGSGeneDx Holdings Corporation
20/11/202322h05GlobeNewswire Inc.GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:WGSGeneDx Holdings Corporation
17/11/202322h15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:WGSGeneDx Holdings Corporation
03/11/202321h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WGSGeneDx Holdings Corporation
30/10/202321h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WGSGeneDx Holdings Corporation
30/10/202321h05GlobeNewswire Inc.GeneDx Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:WGSGeneDx Holdings Corporation
23/10/202323h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WGSGeneDx Holdings Corporation
09/10/202322h05GlobeNewswire Inc.GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023NASDAQ:WGSGeneDx Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:WGS

Kürzlich von Ihnen besucht

TSX
SCL
ShawCor
NYSE
BV
BrightView
BIT
I08980
Intesa Sanpaolo
COIN
JULLETH
JUL (JustLiquidity)
TSXV
VLA
Vela Minerals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten